by Five Rivers Rx | Feb 26, 2019 | Regulations
Patchwork of Regulation As anyone who works in the state licensing realm can tell you, the system of state licensing for pharmaceutical entities is a true patchwork of different rules and regulations. Each state has its own regulatory system. Differences may range...
by Five Rivers Rx | Jan 4, 2019 | Industry News, Regulations
The first-time inspection of a wholesale drug distributor for DSCSA requirements is a warning to industry: be prepared for a knock on the door by the FDA. Why It’s Important For the very first time, the US Food and Drug Administration (FDA) performed an inspection and...
by Five Rivers Rx | Oct 9, 2018 | Regulations
Background In a letter dated May 23, 2018, AmerisourceBergen threatened to stop supply to Bernie’s Pharmacy because of “an elevated percentage of opioid purchasing…specifically, it was noted that in recent months between 25-50% of all pharmacy purchases of Rx products...
by Five Rivers Rx | May 9, 2018 | Competition, Industry News
In an attempt to rein in the Opioid Epidemic, it seems that recently, the DEA has become more vigilant on Suspicious Order Monitoring and Reporting. May 7 Update Morris and Dickson was awarded a temporary restraining order which allows them to continue transacting...
by Five Rivers Rx | Aug 10, 2017 | Competition
The Big 3 have controlled over 90% of the wholesale drug market for over 10 years. At that size, they are close to a zero-sum game… there is no new business to win except from each other or through acquisitions that are limited on supply. PROFIT & SALES GROWTH...
